S
Sophie de Guibert
Researcher at University of Rennes
Publications - 68
Citations - 1982
Sophie de Guibert is an academic researcher from University of Rennes. The author has contributed to research in topics: Rituximab & Chronic lymphocytic leukemia. The author has an hindex of 17, co-authored 60 publications receiving 1684 citations. Previous affiliations of Sophie de Guibert include French Institute of Health and Medical Research.
Papers
More filters
Journal ArticleDOI
Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: results of the GELA-GOELAMS FL2000 study
Gilles Salles,Nicolas Mounier,Sophie de Guibert,Franck Morschhauser,Chantal Doyen,Jean-François Rossi,Corinne Haioun,Pauline Brice,Beatrice Mahe,Reda Bouabdallah,Bruno Audhuy,Christophe Fermé,Caroline Dartigeas,Pierre Feugier,Catherine Sebban,Luc Xerri,Charles Foussard +16 more
TL;DR: With a 5-year follow-up, the combination of rituximab with CHVP+I provides superior disease control in follicular lymphoma patients despite a shorter duration of chemotherapy.
Journal ArticleDOI
Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories
Régis Peffault de Latour,Jean Yves Mary,Celia Salanoubat,Louis Terriou,Gabriel Etienne,Mohamad Mohty,Sophie Roth,Sophie de Guibert,Sébastien Maury,Jean-Yves Cahn,Gérard Socié +10 more
TL;DR: Although clinical presentation and prognosis factors are different, classic PNH and AA-PNH syndrome present roughly similar outcomes, affected mainly by complications.
Journal ArticleDOI
Obinutuzumab (GA101) in relapsed/refractory chronic lymphocytic leukemia: final data from the phase 1/2 GAUGUIN study.
Guillaume Cartron,Sophie de Guibert,Marie-Sarah Dilhuydy,Franck Morschhauser,Véronique Leblond,Jehan Dupuis,Beatrice Mahe,Reda Bouabdallah,Guiyuan Lei,Michael Wenger,Elisabeth Wassner-Fritsch,Michael Hallek +11 more
TL;DR: Obinutuzumab monotherapy is active in patients with heavily pretreated relapsed/refractory CLL and best overall response was 62% and 30%, respectively.
Journal ArticleDOI
Diagnostic and prognostic impact of 18F-FDG PET/CT in follicular lymphoma.
Ludovic Le Dortz,Sophie de Guibert,Sahar Bayat,Anne Devillers,Roch Houot,Yan Rolland,Marc Cuggia,Florence Le Jeune,Haïfa Bahri,Marie-Luce Barge,Thierry Lamy,Etienne Garin +11 more
TL;DR: FDG PET/CT is useful for staging and assessing the prognosis and therapeutic response of patients with follicular lymphoma and was able to predict patients’ outcomes.
Journal ArticleDOI
Allogeneic stem cell transplantation in paroxysmal nocturnal hemoglobinuria
Régis Peffault de Latour,Hubert Schrezenmeier,Andrea Bacigalupo,Didier Blaise,Carmino Antonio De Souza,Stephane Vigouroux,Roelf Willemze,Louis Terriou,André Tichelli,Mohamad Mohty,Sophie de Guibert,Judith C. W. Marsh,Jakob Passweg,Jean Yves Mary,Gérard Socié +14 more
TL;DR: Allogeneic stem cell transplantation is probably not a suitable treatment option for life-threatening thromboembolism in paroxysmal nocturnal hemoglobinuria.